MDA
PFE icon

Minot DeBlois Advisors’s Pfizer PFE Stock Holding History

Minot DeBlois Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$662K Sell
27,487
-27
-0.1% -$706 0.57% 50
2026
Q1 		$773K Buy
27,514
+668
+2% +$17.8K 0.7% 46
2025
Q4 		$668K Buy
26,846
+128
+0.5% +$3.23K 0.6% 52
2025
Q3 		$681K Buy
26,718
+250
+0.9% +$6.17K 0.62% 50
2025
Q2 		$642K Buy
26,468
+290
+1% +$6.76K 0.61% 50
2025
Q1 		$663K Sell
26,178
-522
-2% -$13.7K 0.66% 50
2024
Q4 		$708K Buy
+26,700
New +$724K 0.65% 51

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Minot DeBlois Advisors's PFE Position: Q2 2026 in Review

Minot DeBlois Advisors reduced its Pfizer (PFE) stake by 0.1% in Q2 2026, selling an estimated $706 and leaving 27,487 shares worth $662K. The position accounts for 0.57% of the portfolio, ranked #50.

Minot DeBlois Advisors first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $773K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Minot DeBlois Advisors held 27,487 shares of Pfizer worth $662K as of Q2 2026.
  • Minot DeBlois Advisors sold 27 Pfizer shares in Q2 2026, an estimated $706.
  • Pfizer made up 0.57% of Minot DeBlois Advisors's portfolio in Q2 2026, its #50 holding.
  • Minot DeBlois Advisors first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Minot DeBlois Advisors's Pfizer position peaked at $773K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Minot DeBlois Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.